Zacks Research Has Negative Outlook of McKesson Q3 Earnings

McKesson Co. (NYSE:MCK) – Investment analysts at Zacks Research reduced their Q3 2026 earnings estimates for McKesson in a research report issued to clients and investors on Tuesday, February 25th. Zacks Research analyst R. Department now expects that the company will earn $9.56 per share for the quarter, down from their prior estimate of $10.02. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Zacks Research also issued estimates for McKesson’s Q2 2027 earnings at $9.03 EPS.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%.

A number of other research firms also recently commented on MCK. Baird R W raised McKesson from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 7th. Bank of America dropped their price target on shares of McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Evercore ISI raised their price objective on shares of McKesson from $650.00 to $675.00 and gave the company an “outperform” rating in a research report on Thursday, February 6th. Citigroup dropped their target price on shares of McKesson from $713.00 to $677.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Finally, Robert W. Baird upgraded shares of McKesson from a “neutral” rating to an “outperform” rating and raised their target price for the stock from $531.00 to $688.00 in a report on Thursday, November 7th. Two equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $645.79.

McKesson Stock Performance

NYSE:MCK opened at $621.03 on Friday. The stock has a market cap of $77.83 billion, a price-to-earnings ratio of 28.44, a PEG ratio of 1.29 and a beta of 0.52. McKesson has a 1 year low of $464.42 and a 1 year high of $637.51. The business has a fifty day moving average of $592.91 and a 200-day moving average of $563.46.

Institutional Investors Weigh In On McKesson

Several institutional investors and hedge funds have recently bought and sold shares of MCK. Capital A Wealth Management LLC bought a new position in shares of McKesson in the fourth quarter worth about $26,000. Millstone Evans Group LLC bought a new position in McKesson in the 4th quarter valued at approximately $28,000. MidAtlantic Capital Management Inc. bought a new stake in shares of McKesson during the third quarter worth $29,000. RPg Family Wealth Advisory LLC bought a new stake in shares of McKesson during the third quarter worth $31,000. Finally, Synergy Asset Management LLC bought a new position in shares of McKesson in the 4th quarter valued at $32,000. Institutional investors own 85.07% of the company’s stock.

Insider Activity at McKesson

In other news, CEO Brian S. Tyler sold 8,961 shares of the company’s stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $597.99, for a total value of $5,358,588.39. Following the transaction, the chief executive officer now owns 60,664 shares of the company’s stock, valued at approximately $36,276,465.36. This represents a 12.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Leann B. Smith sold 579 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $602.81, for a total value of $349,026.99. Following the transaction, the executive vice president now owns 1,443 shares in the company, valued at $869,854.83. The trade was a 28.64 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 19,268 shares of company stock valued at $11,536,378. Insiders own 0.11% of the company’s stock.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 3rd will be issued a dividend of $0.71 per share. The ex-dividend date is Monday, March 3rd. This represents a $2.84 annualized dividend and a yield of 0.46%. McKesson’s payout ratio is presently 13.00%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.